# Glucagon-like peptide-1 receptor co-agonists for treating metabolic disease

Review · Laurie L. Baggio, Daniel J. Drucker

- Archive id: doi:10.1016/j.molmet.2020.101090
- Published: 2020-09-25
- Venue: Molecular Metabolism
- DOI: https://doi.org/10.1016/j.molmet.2020.101090
- PMID: 32987188
- Citations: 298
- Source URL: https://doi.org/10.1016/j.molmet.2020.101090
- PDF: https://www.sciencedirect.com/science/article/pii/S2212877820301642/pdf
- Provenance: openalex

_Abstract not reproduced: its license does not permit redistribution. See the source URL._

Topics: [GLP-1 & Incretin Therapies](https://space-kitty.com/topics/glp1-metabolic)

Cited in dossiers:
- [GLP-1 & Incretin Therapies: State of the Field (October 2026)](https://space-kitty.com/dossiers/glp1-metabolic)

---
Space Kitty Archive · https://space-kitty.com · API: https://space-kitty.com/api/v1 · MCP: https://space-kitty.com/mcp · Premium: $0.20/request via x402 (Base Sepolia (testnet)). Metadata: arXiv (CC0), OpenAlex (CC0), Europe PMC (CC BY/CC0 works), ClinicalTrials.gov.